SPONSOR
Genentech, Inc.
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 1
Conditions studied: Geographic AtrophyAtherosclerosisAdvanced Prostate CancerMetastatic Prostate Cancer
Genentech, Inc. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Geographic Atrophy, Atherosclerosis, Advanced Prostate Cancer, Metastatic Prostate Cancer.
The trial portfolio spans Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Genentech, Inc.
How many clinical trials has Genentech, Inc. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Genentech, Inc., of which 3 are actively recruiting participants. These trials cover conditions including Geographic Atrophy, Atherosclerosis, Advanced Prostate Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Genentech, Inc. research focus on?
Genentech, Inc. clinical trials span Geographic Atrophy, Atherosclerosis, Advanced Prostate Cancer, Metastatic Prostate Cancer. The research pipeline includes Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Genentech, Inc. clinical trial?
To participate in a Genentech, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Genentech, Inc. trials with current recruitment status updated daily.
Clinical Trials by Genentech, Inc.
NCT05626114 Phase 2
Recruiting
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
Geographic Atrophy
NCT07448038 Phase 2
Recruiting
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
Atherosclerosis
NCT05800665 Phase 1
Recruiting
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Advanced Prostate Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology